EUCRISA DIN 02476991
Health Canada record
| Active ingredient(s) | CRISABOROLE 2 % |
|---|---|
| Dosage form | Ointment |
| Route | Topical |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | D11AH06 CRISABOROLE |
| Original market date | 29-Aug-2018 |
| Current status date | 29-Aug-2018 |
| Source | Health Canada DPD |
Establishment licence of the holder
Pfizer Canada ULC — licence 100255, currently licensed, last inspection rating C (2023-08-07).
No Canadian shortage report is currently matched to this DIN.
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 20950 | 2018-06-07 | New Drug Submission (NDS) |
International API supply for CRISABOROLE
11 active FDA Drug Master Files.
Request a quote for EUCRISA